Related Experiment Videos
Rapid volume replacement with warmed blood and fluids.
R E Falcone1, S J Fried, P Zeeb
1Department of Cardiovascular Services, Grant Medical Center, Columbus, Ohio.
Angiology
|November 1, 1989
Summary
This study shows that the rapid administration of solutions (RSAS) set is effective for quickly warming and infusing fluids and blood in severe traumatic shock patients. The RSAS device safely improved patient vitals and survival rates.
Area of Science:
- Emergency Medicine
- Trauma Surgery
- Critical Care
Background:
- Severe traumatic shock presents significant resuscitation challenges.
- Rapid infusion and warming of fluids and blood are critical for improving outcomes.
- Existing methods may have limitations in efficiency and safety.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of a novel set for rapid administration of solutions (RSAS).
- To assess the impact of RSAS on resuscitation parameters and survival in severe traumatic shock patients.
Main Methods:
- A prospective clinical study involving 50 consecutive patients with severe traumatic shock.
- Utilized the RSAS for rapid infusion and simultaneous warming of blood and fluids.
- Monitored patient vitals, fluid volumes, and survival rates pre- and post-resuscitation.
Main Results:
- RSAS facilitated infusion of large volumes: 4,632 mL blood, 1,914 mL blood products, 11,248 mL crystalloid in 24 hours.
- Post-resuscitation vitals improved: systolic BP from 71 to 120 mmHg, pulse from 105 to 96 bpm, temperature from 34.3 to 34.9°C.
- Achieved a 24-hour survival rate of 58% (29/50 patients) with no local complications or infusion-related coagulopathy.
Conclusions:
- The RSAS is an effective and safe device for rapid, body-temperature fluid and blood resuscitation in severe traumatic shock.
- RSAS use is associated with improved hemodynamic stability and survival.
- The device offers a valuable tool for managing critically ill trauma patients.